Продажи Изменить Дата
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amarin USD 49.22M 451K 2025-12
Amgen USD 10.4B 300M 2026-09
Arrowhead Research USD 450.82M 375.59M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Biogen USD 2.8B 60M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
Incyte USD 1.56B 110M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
Moderna USD 1.31M 98.69M 2026-09
Neurocrine Biosciences USD 1.12B 161M 2026-09
Novartis USD 14.52B 112M 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09